Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy

被引：0
|
作者：
Chin, Joseph L. [1 ]
机构：
[1] Univ Western Ontario, London Hlth Sci Ctr, Dept Surg Urol, 800 Commissioners Rd East, London, ON N6A5W9, Canada
来源：
EUROPEAN UROLOGY | 2018年 / 73卷 / 05期
关键词：
ADJUVANT RADIOTHERAPY; CANCER; TRIAL;
D O I：
10.1016/j.eururo.2017.12.013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 808
页数：1
相关论文
共 50 条
  • [1] Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy
    Fossati, Nicola
    Karnes, R. Jeffrey
    Colicchia, Michele
    Boorjian, Stephen A.
    Bossi, Alberto
    Seisen, Thomas
    Di Muzio, Nadia
    Cozzarini, Cesare
    Chiorda, Barbara Noris
    Fiorino, Claudio
    Gandaglia, Giorgio
    Dell'Oglio, Paolo
    Shariat, Shahrokh F.
    Goldner, Gregor
    Joniau, Steven
    Battaglia, Antonino
    Haustermans, Karin
    De Meerleer, Gert
    Fonteyne, Valerie
    Ost, Piet
    Van Poppel, Hendrik
    Wiegel, Thomas
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY, 2018, 73 (03) : 436 - 444
  • [2] Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy
    Lee, LW
    McBain, CA
    Swindell, R
    Wylie, JP
    Cowan, RA
    Logue, JP
    CLINICAL ONCOLOGY, 2004, 16 (08) : 517 - 522
  • [3] Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy
    Fossati, Nicola
    Karnes, R. Jeffrey
    Cozzarini, Cesare
    Fiorino, Claudio
    Gandaglia, Giorgio
    Joniau, Steven
    Boorjian, Stephen A.
    Goldner, Gregor
    Hinkelbein, Wolfgang
    Haustermans, Karin
    Tombal, Bertrand
    Shariat, Shahrokh
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Van Poppel, Hein
    Wiegel, Thomas
    Briganti, Alberto
    EUROPEAN UROLOGY, 2016, 69 (04) : 728 - 733
  • [4] Management of patients with rising prostate-specific antigen after radical prostatectomy
    Laufer, M
    Pound, CR
    Carducci, MA
    Eisenberger, MA
    UROLOGY, 2000, 55 (03) : 309 - 315
  • [5] Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
    Bulychkin, P., V
    Tkachev, S., I
    Matveev, V. B.
    Nazarenko, A., V
    ONKOUROLOGIYA, 2019, 15 (02): : 66 - 72
  • [6] OUTCOME AFTER CONFORMAL SALVAGE RADIOTHERAPY IN PATIENTS WITH RISING PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY
    Geinitz, Hans
    Riegel, Martina G.
    Thamm, Reinhard
    Astner, Sabrina T.
    Lewerenz, Carolin
    Zimmermann, Frank
    Molls, Michael
    Nieder, Carsten
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1930 - 1937
  • [7] Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature
    Ploussard, Guillaume
    Fossati, Nicola
    Wiegel, Thomas
    D'Amico, Anthony
    Hofman, Michael S.
    Gillessen, Silke
    Mottet, Nicolas
    Joniau, Steven
    Spratt, Daniel E.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 150 - 169
  • [8] Salvage Radiation Therapy for Increasing Prostate-Specific Antigen After Radical Prostatectomy: Who, When, and How?
    Fossati, Nicola
    Cozzarini, Cesare
    Fiorino, Claudio
    Gandaglia, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 469 - +
  • [9] Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy
    Cox, JD
    Gallagher, MJ
    Hammond, EH
    Kaplan, RS
    Schellhammer, PF
    Crook, JM
    Leibel, SA
    Forman, JD
    Grimm, PD
    Zietman, AL
    Hudson, MA
    Schild, SA
    Beyer, DC
    Hussey, DH
    Thames, H
    Shipley, WU
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1155 - 1163
  • [10] Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur
    Audenet, Francois
    Seringe, Elise
    Drouin, Sarah J.
    Comperat, Eva
    Cussenot, Olivier
    Bitker, Marc-Olivier
    Roupret, Morgan
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 239 - 244
12345